Popular Weight-Loss Drug Wegovy Unveils Subscription Service
Published on March 31, 2026.
Novo Nordisk is launching a subscription service for its popular GLP-1 weight loss drug, Weg. The service will offer lower prices for both the injectable and the pill through three telehealth services. This move is part of a wider effort by drug companies to reduce prices and attract more patients.
Related Articles
Young N.J. kids keep eating weed gummies and end up in hospital. Lock up your edibles.
Aneurinolololized New Jersey's Poison Control Center reports a steady increase in children under age 6 eating marijuana edibles, urging lockable bags to prevent accidental exposures.
Woman without a womb helps to deliver her own baby
The article discusses the importance of giving birth to a child without a mother, and the significance of the newborns being born and bred in the UK.
Popular West El Paso burrito restaurant receives low inspection score
Aristos.com.com (N.)